Abnormal age-related changes of plasma antioxidant proteins in schizophrenia

Psychiatry Research

Volumn 97, Issue 2-3, 2000, Pages 137-151

  Yao, Jeffrey K ^a,b   Reddy, Ravinder ^b   Van Kammen, Daniel P ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

Age; Albumin; Bilirubin; Haloperidol; Plasma; Psychosis; Total antioxidant status

Indexed keywords

ALBUMIN; ANTIOXIDANT; BILIRUBIN; HALOPERIDOL; SUPEROXIDE DISMUTASE;

AGE; ANTIOXIDANT ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGE FACTORS; AGING; ALBUMINS; ANTIPSYCHOTIC AGENTS; ANXIETY; BILIRUBIN; DEPRESSION; HALOPERIDOL; HUMANS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 0034722915     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(00)00230-4     Document Type: Article

References (70)

1. Oxidative stress in brain caused by 6-hydroxydopamine. A model for schizophrenia
2. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic depressive patients
3. Negative symptoms in schizophrenia: Definition and reliability
4. Vitamin E, lipids, lipid peroxidation products and tardive dyskinesia
5. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: Relation to psychosocial variables
6. Glutathione peroxidase and CT scan abnormalities in schizophrenia
7. Methods for reliable longitudinal observation of behavior
8. Vitamin E and cigarette smoking-induced oxidative damage
9. Effects of the antioxidant butyrated hydroxyltoluene (BHT) on mortality in BALB/C mice
10. Effect of ethoxyquin on longevity of C3H mice
11. Albumin standards and the measurement of serum albumin with bromocresol green
12. Sensitive electrochemical high-performance liquid chromatography assay for the simultaneous determination of haloperidol and reduced haloperidol
13. Aging: Is oxidative stress a marker or is it causal?
14. A fluorescence-based method for measuring total plasma antioxidant capacity
15. Indices of lipid free-radical oxidation and the antiradical protection of the brain-the neurochemical correlates of the development of the general adaptation syndrome
16. Blood cotinine levels as indicators of smoking treatment outcome
17. Aging and disease: Extending functional life span
18. Aging prospects for future increases in the functional life span
19. The aging
20. Effect of dietary 2-mercaptoethanol on the life span, immune system, tumor incidence and lipid peroxidation damage in spleen lymphocytes of aging BC3F mice
21. Increased superoxide dismutase activity in aged human cerebrospinal fluid and rat brain determined by electron spin resonance spectrometry using spin trap method
22. Comparison of tests used to distinguish smokers from non-smokers
23. Oxidative stress and superoxide dismutase in schizophrenia
24. Nicotine and its metabolites, radioimmunoassay for nicotine and cotinine
25. Quantitation of cotinine in sera of smokers
26. Oxygen radicals and neuropsychiatric illness: Some speculations
27. Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia
28. Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics
29. Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs
30. Free radical pathology and antioxidant defense in schizophrenia: A review
31. Membrane peroxidation and the neuropathology of schizophrenia
32. Superoxide dismutase activity in developing rat brain
33. The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and normal subjects
34. Clinical aspects of the dosage of erythrocuprein
35. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates
36. Mitochondrial role in cell aging
37. Disorders of the oxidative stress defense system in senescence-accelerated mice (SAM), and prolongation of life span by supplementation with antioxidants and free radical spin traps
38. The antioxidant defense system at the onset of psychosis
39. Concepts and effects of intervention studies with antioxidative trace elements in humans
40. The brief psychiatric rating scale
41. Determinants of antioxidant status in humans
42. Detection and measurement of total bilirubin in serum, with use of surfactants as solubilizing agents
43. Oxidants in cigarette smoke
44. Plasma antioxidants are strongly affected by iron-induced lipid peroxidation in rats subjected to physical exercise and different dietary fats
45. Enzymes of the antioxidant system in chronic schizophrenic patients
46. Free radical pathology in schizophrenia: A review
47. Membrane protective strategies in schizophrenia: Conceptual and treatment issues
48. Oxidative damage and mitochondrial decay in aging
49. Measurement of protein using bicinchoninic acid
50. Oxidative reactions and schizophrenia: A review-discussion
51. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging in response to food restriction in the mouse
52. Antioxidant potential of anaerobic human plasma: Role of serum albumin and thiols as scavengers of carbon radicals
53. Use of smokeless tobacco and cigarettes - Effects on plasma levels of antioxidant vitamins
54. Vitamin C status in chronic schizophrenia
55. Predicting duration of clinical stability following haloperidol withdrawal in schizophrenia
56. Behavioral vs. biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia
57. Elevated CSF NE and relapse in schizophrenia
58. Superoxide dismutase activity in aging rat brain
59. The relative contribution of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma
60. Unequivocal evidence in support of the non-enzymatic redox coupling between glutathione/glutathione disulfide and ascorbic acid/dehydroascorbic acid
61. Acute phase proteins in male Chinese schizophrenic patients in Singapore
62. Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia
63. Red blood cell and platelet fatty acid metabolism in schizophrenia
64. Fatty acids and psychiatric disorders
65. Effects of haloperidol on antioxidant defense system enzymes in schizophrenia
66. Reduced status of plasma total antioxidant capacity in schizophrenia
67. Reduced level of plasma antioxidant uric acid in schizophrenia
68. Superoxide dismutase and negative symptoms in schizophrenia
69. Human plasma glutathione peroxidase and symptom severity in schizophrenia